Slater Technology Fund


Slater Technology Fund is Rhode Island’s oldest and most active seed-stage investment fund, focusing on supporting innovative startups and fostering economic growth in the region. The fund is committed to investing in promising companies, particularly those emerging from academic institutions like Brown University, and aims to drive technological advancements and entrepreneurial success.

Slater Technology Fund

Slater Technology Fund


Portfolio

Secured $375,000 in funding from Slater Technology Fund to develop treatments for chronic heart and pulmonary conditions.

#Biotechnology

Raised $835,000 in a new round of funding led by Slater Technology Fund.

#Sales and Marketing Technology

Raised $1.5 million to develop antisense oligonucleotides for promoting neurogenesis.

#Biotechnology

Awarded $1.15 million grant from the U.S. Dept. of Energy to commercialize a new blade coating for wind turbines.

#Renewable Energy

Oversubscribed $4 million Series A financing to accelerate commercialization and product development.

#Medical Technology

Launched the IlluminOss Bone Stabilization System in the U.S.

#Medical Devices

Received $25,000 investment to build a platform for K-12 tutoring.

#EdTech

Entered a global licensing agreement with Takeda to develop plasma-derived therapy.

#Biotechnology

Acquired by Novartis in a deal worth up to $770 million.

#Biotechnology

Developing synthetic molecules for treating ovarian cancer.

#Pharmaceuticals

Reinvested in a promising drug discovery venture based at the Ryan Institute for Neuroscience at URI.

#Biotechnology

Expanding nationwide from its headquarters in Rhode Island.

#Technology-Enabled Services